Back

Daniel B. Brown, M.D.

Attending Physician
Vanderbilt University Medical Center

Presentation(s):

Metastatic Liver Tumors: Genomic and molecular biomarkers for CRC, neuroendocrine
Sunday, March 5, 2023
9:20 AM – 9:30 AM
Disclosure information not submitted.
Comparison of 90Y Radioembolization Outcomes for Hepatocellular Carcinoma (HCC) in TACE-refractory (T-REF) vs Treatment Naïve (TN) Patients in the RESiN Registry (NCT: 02685631)
Sunday, March 5, 2023
3:45 PM – 3:54 PM
Disclosure information not submitted.
Progression and Survival Outcomes of Hepatocellular Carcinoma (HCC) Patients within Milan Criteria Following Y90 Radioembolization Using the Radiation-Emitting SIR-Spheres in Non-Resectable Tumor (RESiN) Registry NCT 02685631
Sunday, March 5, 2023
3:54 PM – 4:03 PM
Disclosure information not submitted.
Predictive Dosimetry and Outcomes of Hepatocellular Carcinoma Following Liver Resin Microsphere Radioembolization
Monday, March 6, 2023
3:00 PM – 3:09 PM
Disclosure information not submitted.
Comparing Survival Outcomes and Toxicities of Y90 Radioembolization of Colorectal Cancer Metastatic to the Liver Between Patients Older and Younger than 70: Analysis from the RESiN Registry (NCT02685631)
Monday, March 6, 2023
4:12 PM – 4:21 PM
Disclosure information not submitted.
Liquids Tumor/Tissue embolization (AML, Splenic, HCC, etc.)
Tuesday, March 7, 2023
1:45 PM – 2:00 PM
Disclosure information not submitted.
Wednesday Closing Plenary Session: Act Local, Think Global: IR and its role in Immuno-oncology and Abstracts of the Year and Best Posters recognition
Wednesday, March 8, 2023
10:30 AM – 12:00 PM
Disclosure information not submitted.
Q&A: Act Local, Think Global: IR and its role in Immuno-oncology
Wednesday, March 8, 2023
12:30 PM – 1:00 PM
Disclosure information not submitted.
Assessment of Delivery, Dosimetry and Imaging Response with FLEX versus Day of Calibration Resin 90Y microspheres for Hepatocellular Carcinoma
Wednesday, March 8, 2023
3:00 PM – 3:09 PM
Disclosure information not submitted.